Pablo Zapata-Benavides Selected Research

Pablo Zapata-Benavides Research Topics

Disease

14	Neoplasms (Cancer) 06/2020 - 06/2002
7	Melanoma (Melanoma, Malignant) 01/2021 - 12/2007
5	Breast Neoplasms (Breast Cancer) 06/2020 - 06/2002
4	Wilms Tumor (Wilm's Tumor) 01/2017 - 07/2002
3	Veterinary Venereal Tumors (Transmissible Venereal Tumor) 02/2019 - 10/2018
2	Neoplasm Metastasis (Metastasis) 05/2019 - 12/2010
2	Leukemia 12/2016 - 06/2002
2	Infections 01/2015 - 12/2014
1	Inflammation (Inflammations) 11/2021
1	Sepsis (Septicemia) 11/2021
1	Triple Negative Breast Neoplasms 06/2020
1	Lung Neoplasms (Lung Cancer) 05/2019
1	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2018
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2017
1	Hypoalbuminemia 01/2017
1	Hyperlipidemias (Hyperlipidemia) 01/2017
1	Edema (Dropsy) 01/2017
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2016
1	Blast Crisis (Blast Phase) 12/2016
1	Leukopenia 01/2016
1	Neutropenia 01/2016
1	Thrombocytopenia (Thrombopenia) 01/2016
1	Weight Gain 01/2016
1	Virus Diseases (Viral Diseases) 12/2014
1	Acquired Immunodeficiency Syndrome (AIDS) 02/2009
1	Hepatocellular Carcinoma (Hepatoma) 07/2007
1	Lymphoma (Lymphomas) 06/2002

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2017 - 06/2002
3	Messenger RNA (mRNA)IBA 11/2021 - 07/2002
3	Cisplatin (Platino)FDA LinkGeneric 05/2019 - 04/2012
2	WT1 ProteinsIBA 01/2021 - 07/2002
2	Doxorubicin (Adriamycin)FDA LinkGeneric 06/2020 - 04/2012
2	Liposomes (Liposome)IBA 12/2016 - 07/2002
2	Transcription Factors (Transcription Factor)IBA 01/2016 - 04/2012
2	Antiviral Agents (Antivirals)IBA 01/2015 - 12/2014
2	Polysaccharides (Glycans)IBA 01/2015 - 12/2014
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2021
1	nephrinIBA 11/2021
1	InterleukinsIBA 11/2021
1	LipopolysaccharidesIBA 11/2021
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2020
1	Gemcitabine FDA Link 05/2019
1	TetraspaninsIBA 02/2019
1	AlarminsIBA 02/2019
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 02/2019
1	AntigensIBA 02/2019
1	CytokinesIBA 12/2018
1	CalreticulinIBA 12/2018
1	HMGB1 Protein (HMG1)IBA 12/2018
1	Hypochlorous Acid (Hypochlorite)IBA 12/2018
1	Neoplasm Antigens (Tumor Antigens)IBA 12/2018
1	DystrophinIBA 01/2018
1	Antineoplastic Agents (Antineoplastics)IBA 07/2017
1	Immunologic Factors (Immunomodulators)IBA 07/2017
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 07/2017
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2017
1	SteroidsIBA 01/2017
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 12/2016
1	Small Interfering RNA (siRNA)IBA 12/2016
1	Transferrin (beta 2 Transferrin)IBA 12/2016
1	Transfer Factor (Factor, Transfer)IBA 12/2016
1	Saline SolutionIBA 12/2016
1	PlasticsIBA 01/2016
1	Superoxides (Superoxide)IBA 01/2016
1	Interleukin-2 (IL2)IBA 01/2016
1	Transforming Growth Factor beta (TGF-beta)IBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2016
1	Fluorouracil (Carac)FDA LinkGeneric 01/2016
1	fucoidanIBA 12/2014
1	Pharmaceutical PreparationsIBA 11/2012
1	Biological ProductsIBA 11/2012
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2010
1	colloidal silverIBA 11/2010
1	AntioxidantsIBA 11/2010
1	ParaffinIBA 10/2009
1	Progesterone Receptors (Progesterone Receptor)IBA 10/2009
1	Biomarkers (Surrogate Marker)IBA 10/2009
1	Estrogen ReceptorsIBA 10/2009
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 02/2009
1	Subgenomic RNAIBA 07/2007
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 07/2002
1	Cyclin D1IBA 07/2002
1	Tamoxifen FDA LinkGeneric 07/2002
1	OligodeoxyribonucleotidesIBA 07/2002
1	Antisense OligonucleotidesIBA 06/2002

Therapy/Procedure

8	Therapeutics 06/2020 - 06/2002
4	Drug Therapy (Chemotherapy) 06/2020 - 06/2002
3	Immunotherapy 02/2019 - 10/2018
1	Oral Administration 01/2019
1	Traditional Medicine (Folk Remedies) 01/2019
1	Complementary Therapies (Alternative Medicine) 10/2018